The quota for retail investors was subscribed 0.44 times shares of the allotted quota, while the portion set aside for ...

Investors in all categories responded ambivalently to the Suraksha Diagnostic IPO on Monday, December 2, the second day of ...

The quota for retail investors was subscribed 0.89 times shares of the allotted quota, while the portion set aside for ...

Suraksha Diagnostic IPO subscription status was 25% on the second bidding day. The initial share sale, valued at ₹846 crore, ...

The shares of Suraksha Clinic and Diagnostics were not attracting any premium or discount at the grey market. This suggests ...

Suraksha Diagnostic's IPO received a lukewarm response with only 25% subscription by the second day. The structure, being an ...

Suraksha Diagnostic IPO sees weak response, with 37% subscription; analysts advise avoiding due to high valuation and limited ...

Suraksha Diagnostics Limiteds initial public offering (IPO) has entered its final day of subscription, offering investors a ...

The subscription window for the Suraksha Diagnostic IPO closes today. Check the subscription status, GMP, listing schedule, ...

The initial public offering (IPO) of West Bengal-based diagnostic chain Suraksha Diagnostic Ltd. has been subscribed 32% so ...

Ahead of the IPO, Suraksha Diagnostics on Thursday, 28 November 2024, raised Rs 253.87 crore from anchor investors. The board allotted 57.56 crore shares at Rs 441 each to 16 anchor investors.

The IPO will close on. The IPOs equity shares are proposed to be listed on BSE and NSE. The latest grey market premium (GMP) ...